209 related articles for article (PubMed ID: 15579769)
1. Deregulation of estrogen receptor coactivator proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor in human endometrial tumors.
Vadlamudi RK; Balasenthil S; Broaddus RR; Gustafsson JA; Kumar R
J Clin Endocrinol Metab; 2004 Dec; 89(12):6130-8. PubMed ID: 15579769
[TBL] [Abstract][Full Text] [Related]
2. Cloning and functional characterization of PELP1/MNAR promoter.
Mishra SK; Balasenthil S; Nguyen D; Vadlamudi RK
Gene; 2004 Apr; 330():115-22. PubMed ID: 15087130
[TBL] [Abstract][Full Text] [Related]
3. PELP1/MNAR suppression inhibits proliferation and metastasis of endometrial carcinoma cells.
Wan J; Li X
Oncol Rep; 2012 Dec; 28(6):2035-42. PubMed ID: 22992812
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor.
Rajhans R; Nair S; Holden AH; Kumar R; Tekmal RR; Vadlamudi RK
Cancer Res; 2007 Jun; 67(11):5505-12. PubMed ID: 17545633
[TBL] [Abstract][Full Text] [Related]
5. Extranuclear coactivator signaling confers insensitivity to tamoxifen.
Kumar R; Zhang H; Holm C; Vadlamudi RK; Landberg G; Rayala SK
Clin Cancer Res; 2009 Jun; 15(12):4123-30. PubMed ID: 19470742
[TBL] [Abstract][Full Text] [Related]
6. Functional and biological properties of the nuclear receptor coregulator PELP1/MNAR.
Vadlamudi RK; Kumar R
Nucl Recept Signal; 2007 May; 5():e004. PubMed ID: 17525794
[TBL] [Abstract][Full Text] [Related]
7. Novel estrogen receptor coactivator PELP1/MNAR gene and ERbeta expression in salivary duct adenocarcinoma: potential therapeutic targets.
Vadlamudi RK; Balasenthil S; Sahin AA; Kies M; Weber RS; Kumar R; El-Naggar AK
Hum Pathol; 2005 Jun; 36(6):670-5. PubMed ID: 16021574
[TBL] [Abstract][Full Text] [Related]
8. Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2.
Nair SS; Guo Z; Mueller JM; Koochekpour S; Qiu Y; Tekmal RR; Schüle R; Kung HJ; Kumar R; Vadlamudi RK
Mol Endocrinol; 2007 Mar; 21(3):613-24. PubMed ID: 17192406
[TBL] [Abstract][Full Text] [Related]
9. Expression of ERalpha, ERbeta and co-regulator PELP1/MNAR in colorectal cancer: prognostic significance and clinicopathologic correlations.
Grivas PD; Tzelepi V; Sotiropoulou-Bonikou G; Kefalopoulou Z; Papavassiliou AG; Kalofonos H
Cell Oncol; 2009; 31(3):235-47. PubMed ID: 19478391
[TBL] [Abstract][Full Text] [Related]
10. Emerging significance of ER-coregulator PELP1/MNAR in cancer.
Nair S; Vadlamudi RK
Histol Histopathol; 2007 Jan; 22(1):91-6. PubMed ID: 17128415
[TBL] [Abstract][Full Text] [Related]
11. Modulation of in situ estrogen synthesis by proline-, glutamic acid-, and leucine-rich protein-1: potential estrogen receptor autocrine signaling loop in breast cancer cells.
Rajhans R; Nair HB; Nair SS; Cortez V; Ikuko K; Kirma NB; Zhou D; Holden AE; Brann DW; Chen S; Tekmal RR; Vadlamudi RK
Mol Endocrinol; 2008 Mar; 22(3):649-64. PubMed ID: 18079323
[TBL] [Abstract][Full Text] [Related]
12. Potential role of a novel transcriptional coactivator PELP1 in histone H1 displacement in cancer cells.
Nair SS; Mishra SK; Yang Z; Balasenthil S; Kumar R; Vadlamudi RK
Cancer Res; 2004 Sep; 64(18):6416-23. PubMed ID: 15374949
[TBL] [Abstract][Full Text] [Related]
13. Proline-, glutamic acid-, and leucine-rich protein-1 is essential in growth factor regulation of signal transducers and activators of transcription 3 activation.
Manavathi B; Nair SS; Wang RA; Kumar R; Vadlamudi RK
Cancer Res; 2005 Jul; 65(13):5571-7. PubMed ID: 15994929
[TBL] [Abstract][Full Text] [Related]
14. Functional implications of altered subcellular localization of PELP1 in breast cancer cells.
Vadlamudi RK; Manavathi B; Balasenthil S; Nair SS; Yang Z; Sahin AA; Kumar R
Cancer Res; 2005 Sep; 65(17):7724-32. PubMed ID: 16140940
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer.
Aust S; Horak P; Pils D; Pils S; Grimm C; Horvat R; Tong D; Schmid B; Speiser P; Reinthaller A; Polterauer S
BMC Cancer; 2013 Mar; 13():115. PubMed ID: 23497172
[TBL] [Abstract][Full Text] [Related]
16. Functional interactions between the estrogen receptor coactivator PELP1/MNAR and retinoblastoma protein.
Balasenthil S; Vadlamudi RK
J Biol Chem; 2003 Jun; 278(24):22119-27. PubMed ID: 12682072
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of recent biochemical and biologic findings regarding a newly discovered protein-PELP1/MNAR.
Rajhans R; Vadlamudi RK
Clin Exp Metastasis; 2006; 23(1):1-7. PubMed ID: 16826428
[TBL] [Abstract][Full Text] [Related]
18. Altered localization of a coactivator sensitizes breast cancer cells to tumor necrosis factor-induced apoptosis.
Rayala SK; Mascarenhas J; Vadlamudi RK; Kumar R
Mol Cancer Ther; 2006 Feb; 5(2):230-7. PubMed ID: 16505095
[TBL] [Abstract][Full Text] [Related]
19. Identifying the estrogen receptor coactivator PELP1 in autophagosomes.
Ohshiro K; Rayala SK; Kondo S; Gaur A; Vadlamudi RK; El-Naggar AK; Kumar R
Cancer Res; 2007 Sep; 67(17):8164-71. PubMed ID: 17804729
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha.
Vadlamudi RK; Wang RA; Mazumdar A; Kim Y; Shin J; Sahin A; Kumar R
J Biol Chem; 2001 Oct; 276(41):38272-9. PubMed ID: 11481323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]